Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection.

We found no evidence suggesting an association between perioperative analgesia choice and recurrence-free survival or overall survival in patients undergoing surgical resection of stage I NSCLC.